Research To Practice

11 Live Oncology Nursing Webinars — Moderated by Dr Neil Love

View in browser

Oncology Grand Rounds 2020

Oncology Grand Rounds
A Complimentary CNE (NCPD) Live Webinar Series for Oncology Nurses
16.5 ANCC Contact Hours Available

Next Tuesday, May 26 at 5 PM ET, we kick off our annual Oncology Grand Rounds series with new developments in breast cancer. For a glimpse into the agents and strategies we will discuss, check out how faculty member Dr Joyce O’Shaughnessy answers the question “What’s new in breast cancer treatment?"

Neil Love, MD
Research To Practice
Miami, Florida

Register for This Complimentary Nursing Live Webinar Series

All Webinars Will Be Held 5:00 PM - 6:30 PM ET

26
MAY

28
MAY

Gastrointestinal Cancers

2
JUNE

Hodgkin and Non-Hodgkin Lymphomas

4
JUNE

Chronic Lymphocytic Leukemia

9
JUNE

Gynecologic Cancers

11
JUNE

Metastatic Lung Cancer

16
JUNE

Locally Advanced Non-Small Cell Lung Cancer

18
JUNE

Urothelial Bladder Carcinoma

23
JUNE

Chimeric Antigen Receptor T-Cell Therapy

25
JUNE

PARP Inhibition in the Management of Common Cancers

30
JUNE

Prostate Cancer

Research To Practice (RTP) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Each educational activity for 1.5 contact hours is provided by RTP.

Each activity is awarded 1.5 ANCC pharmacotherapeutic contact hours.

These activities will be submitted to the ONCC for ILNA verification.

Prostate Cancer and Urothelial Bladder Carcinoma events jointly provided by USF Health and Research To Practice.

Breast Cancer: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Genentech, a member of the Roche Group, Merck, Novartis, Puma Biotechnology Inc and Seattle Genetics.

Gastrointestinal Cancers: This activity is supported by educational grants from Genentech, a member of the Roche Group, and Taiho Oncology Inc.

Hodgkin and Non-Hodgkin Lymphomas: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Celgene Corporation, Pharmacyclics LLC, an AbbVie Company, and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Seattle Genetics.

Chronic Lymphocytic Leukemia: This activity is supported by educational grants from AbbVie Inc, AstraZeneca Pharmaceuticals LP, Genentech, a member of the Roche Group, and Pharmacyclics LLC, an AbbVie Company, and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC.

Gynecologic Cancers: This activity is supported by educational grants from AbbVie Inc, AstraZeneca Pharmaceuticals LP, Eisai Inc and Merck.

Metastatic Lung Cancer: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP and Merck.

Locally Advanced Non-Small Cell Lung Cancer: This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Urothelial Bladder Carcinoma: This activity is supported by educational grants from Astellas and Seattle Genetics, Genentech, a member of the Roche Group, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Merck.
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

Chimeric Antigen Receptor T-Cell Therapy: This activity is supported by educational grants from Celgene Corporation, Kite, A Gilead Company, and Novartis.

PARP Inhibition: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP and Merck.

Prostate Cancer: This activity is supported by educational grants from Astellas and Pfizer, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Sanofi Genzyme.
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

Research To Practice | 2 South Biscayne Boulevard, Suite 3600 | Miami, FL 33131
Unsubscribe from all communications | Manage subscription